Over 19,000 shares purchased at a cost of around £10.000. Good signs when directors back the business. This company is still under the radar but the share price should correct based on recent good news.
Well this news pretty good: Revenues comfortable Grant income materially higher Operating losses materially lower Continued contract wins Healthy pipeline
Any thoughts on where it could take the price for now?
Broker rating of 132p and previous highs of 145 and 81p seem to give plenty of head-room for rewarding this more commercially solid news than the previous market speculation. I'm going to guess 72p over a week as a more modest reflection of how the market reacted to the MOU with China in December.
Low visibility and high volatility makes for an unpredictable but potentially exciting ride here.
Hi Pickwick. Good to hear you are invested here too. The potential for this company is huge as dementia costs the UK £23 billion a year alone - with a market cap of only £9m there could be massive upside on any progress in development of early diagnosis equipment. This is not without risk but the possibilities are significant. It is also good to invest in a company working towards helping millions of people. Happy to hold and wait for developments, I have no doubt that this company will be noticed in time. All the best.
Hello Gordon. This is one I have bought into and will hold. Dementia is a worldwide affliction that costs governments, so they are keen to find something to alleviate the pressure on their money.
Plus, very small amount of shares around, directors have bought in, news will probably come out of the blue with this one. So wait and see. I will add some in the next month or two if it stays in the 60s.
This company has so much potential but is completely off the radar. All recent news flow has been excellent but a major RNS is required to get this on the map. Anyone who has tried to purchase shares in this company in the past will know how difficult they are to obtain. With the right news this could be many multiples of the current share price. Anyone else out there who is in this too, any views?
China are in the UK for the next few days to discuss potential business opportunities. Whilst the media focus is surrounding energy I wonder if there will be an RNS shortly confirming investment in Ixico. An RNS confirming a MOU was released in December and it has been confirmed in the past that China are keen to research dementia further. A sizeable investment in Ixico could be massive for the share price.
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.